Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...] …
Category: Legislative
After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to [...] …
Provider groups diverged over 340B Medicaid managed care provisions in a sweeping healthcare package on which the House of Representatives [...] …
The future of a Republican drug shortages bill with 340B provisions remains unclear after it was examined in a contentious [...] …
A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...] …
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...] …
A federal appeals court decision striking down parts of an Oklahoma pharmacy benefit manager (PBM) law could jeopardize state laws [...] …
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...] …
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...] …
Republican leaders of the U.S. House Energy and Commerce (E&C) Committee released a draft bill late last week that would [...] …